Clinical trials
Diabetes Mellitus, Type 1 trials in Israel with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 11 |
| Terminated | 7 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rabin Medical Center | 28 |
| Sheba Medical Center | 7 |
| Assaf-Harofeh Medical Center | 3 |
| Medtronic MiniMed, Inc. | 3 |
| Assuta Hospital Systems | 2 |
| Antea Foundation | 1 |
| Carmel Medical Center | 1 |
| Clalit Health Services | 1 |
| DreaMed Diabetes | 1 |
| HaEmek Medical Center, Israel | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 57 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Diabetes, Gestational | 2 |
| Autoimmune Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Fatty Liver | 1 |
| Frailty | 1 |
| Glucose Intolerance | 1 |
| Hypoglycemia | 1 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.